Catalyst Wire Dossier Catalyst Wire Dossier

SM-030 Gel

· DermBiont, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SM-030 Gel, covering 2024-12-13 to 2024-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Randomized Study Using SM-030 Gel for Adults With Melasma [Phase 2]

See pricing